Abstract

LOPEZ BARRIOS, Víctor M.  and  SAENZ MADRIGAL, Manuel E.. Anafilaxia tras la aplicación de la vacuna de la COVID-19: lo que debemos saber. Rev. costarric. cardiol [online]. 2024, vol.26, n.2, pp.5-10. ISSN 1409-4142.

The rapid approval and distribution of COVID-19 vaccines have represented a significant milestone in the fight against the pandemic. However, concerns have arisen regarding potential adverse effects, particularly anaphylaxis, an acute and immediate allergic reaction that affects multiple body systems. Early detection is crucial for appropriate treatment, which includes the use of epinephrine. COVID-19 vaccines contain certain excipients such as polyethylene glycol (PEG) and polysorbate 80, which can trigger allergic reactions. While patients with common allergies are not more likely than the general public to have an allergic reaction to the COVID-19 vaccine and therefore should not abstain from vaccination, given the severity of the condition, healthcare professionals at vaccination centers must be vigilant for early signs and symptoms of anaphylaxis and have the necessary medications and equipment for its treatment. Thus, the aim of this review is to provide physicians with the necessary information to understand the phenomenon of anaphylaxis following COVID-19 vaccination, its prevention, diagnosis, and treatment.

Keywords : COVID-19; anaphylaxis; vaccines.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )